Anthropometric and biochemical characteristics of patients with NAFLD

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease states, from steatosis (fatty liver) to non-alcoholic steatohepatitis (also called NASH steatosis with inflammatory changes) followed by a progression to fibrosis and cirrhosis and hepatocellular carcinoma. Excess liver fat is believed to be a manifestation of the metabolic syndrome and not surprisingly NAFLD is associated with obesity, insulin resistance, dyslipidemia and type 2 diabetes in humans. There are ways to prevent NAFLD: - Maintain a healthy weight - Eat a healthy diet - Exercise regularly - Limit alcohol intake - Only take medicines that you need and follow dosing recommendations.

Autorentext

Tatjana R. Novakovic is a Professor in the Department of Internal medicine at the University of Kosovska Mitrovica. Dr Novakovic graduated in Medicine in Pristina. In 1990, she joined the Department of Endocrinology KBC Pristina and subsequently trained as a specialist endocrinologist in Belgrade. She received the title of professor in 2001.